Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies
1 clinical trials · Condition
◉ Watch Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies
| Record | Firm | Date |
|---|---|---|
| Trial of TRX518 (Anti-GITR mAb) in Stage III or IV Malignant Melanoma or Other Solid Tumors (NCT01239134) | Leap Therapeutics, Inc. | 2010-10-01 |
Track Unresectable Stage III or Stage IV Malignant Melanoma or Other Solid Tumor Malignancies automatically
Every clearance here is in the API, with alerts when new ones post.